Hikma Pharmaceuticals PLC (HIK.L) LSE
1,421.00
-1(-0.07%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 4.6B |
| Enterprise Value | 5.92B |
| P/E Ratio | 10.46 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 1.21 |
| Price/Book Ratio | 1.62 |
| Enterprise/Revenue | 1.61 |
| Enterprise/EBITDA | 8.06 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.12 |
| Operating Margin | 0.17 |
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.16 |
Income Statement
| Revenue | 3.42B |
| Revenue/Share | 15.25 |
| Gross Profit | 1.37B |
| EBITDA | 853.54M |
| Net Income | 410.43M |
| Diluted EPS | 1.84 |
Balance Sheet
| Total Cash | 354.13M |
| Total Cash/Share | 1.61 |
| Total Debt | 1.65B |
| Total Debt/Equity | 0.64 |
| Current Ratio | 1.82 |
| Book Value Per Share | 11.84 |
Price History
| 52-Week Change | -33.85 |
| 52-Week High | 2,156 |
| 52-Week Low | 1,187 |
| Moving Average 50 Days | 1,376.65 |
| Moving Average 200 Days | 1,535.94 |
Statistics
| Average Volume | 1.12M |
| Shares Outstanding | 213.03M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.83 |
| Trailing Annual Dividend Yield | 4.35 |
| Payout Ratio | 0.45 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
